Edition:
United Kingdom

Recro Pharma Inc (REPH.OQ)

REPH.OQ on NASDAQ Stock Exchange Capital Market

8.56USD
23 Feb 2018
Change (% chg)

$-0.05 (-0.58%)
Prev Close
$8.61
Open
$8.68
Day's High
$8.76
Day's Low
$8.51
Volume
28,628
Avg. Vol
25,212
52-wk High
$10.55
52-wk Low
$5.85

Latest Key Developments (Source: Significant Developments)

Recro Pharma - ‍Ryan Lake Promoted To CFO
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - Recro Pharma Inc ::RECRO PHARMA INC - ‍RYAN D. LAKE HAS BEEN PROMOTED TO CHIEF FINANCIAL OFFICER​.  Full Article

Recro Pharma Says Entered Into A Sales Agreement With Cowen And Co‍​
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Recro Pharma Inc ::RECRO PHARMA INC - ENTERED INTO A SALES AGREEMENT WITH COWEN AND COMPANY‍​.RECRO PHARMA - PURSUANT TO AGREEMENT, CO MAY SELL FROM TIME TO TIME, COMMON STOCK SHARES, $0.01 PAR VALUE/SHARE, WITH OFFERING PRICE OF UP TO $40 MILLION.  Full Article

Recro Pharma secures $100 million credit facility
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Recro Pharma Inc :Recro Pharma Inc secures $100 million credit facility.Recro Pharma Inc - ‍has secured a $100 million credit facility from funds managed by Athyrium Capital Management, LP​.Recro Pharma Inc - ‍proceeds from facility to refinance Recro's outstanding debt, pay $45 million milestone to alkermes upon approval of iv meloxicam 30mg by FDA​.  Full Article

Recro Pharma reports Q3 revenue $17.1 million
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Recro Pharma Inc :Recro Pharma reports third quarter 2017 financial results.Q3 revenue $17.1 million versus I/B/E/S view $13.7 million.Recro Pharma Inc - ‍Raising its guidance for 2017 revenue from a range of $60-$63 million to $65 million​.Recro Pharma Inc qtrly ‍revenues were $17.1 million versus $17.0 million​.Recro Pharma Inc - ‍As of September 30, 2017, Recro had cash, cash equivalents and short-term investments of $41.3 million​.  Full Article

Recro Pharma says offering of 6.50 mln shares priced at $6/share
Tuesday, 13 Dec 2016 

Recro Pharma Inc: Recro Pharma announces pricing of public offering of common stock .Says public offering of 6.50 million common shares priced at $6.00 per share.  Full Article

Recro reports pricing of public offering of common stock
Tuesday, 16 Aug 2016 

Recro Pharma Inc : Recro Pharma announces pricing of public offering of common stock .Recro Pharma Inc says pricing of an underwritten public offering of 1,986,666 shares of its common stock at a price of $7.50 per share.  Full Article

Recro Pharma announces proposed public offering of common stock
Monday, 15 Aug 2016 

Recro Pharma Inc :Recro pharma announces proposed public offering of common stock.  Full Article

Recro Pharma Q2 loss per share $0.83
Thursday, 11 Aug 2016 

Recro Pharma Inc : Recro Pharma reports second quarter 2016 financial results . Q2 revenue $17.3 million versus $18.7 million .Sees FY 2016 revenue $55 million to $60 million.  Full Article

Recro Pharma appoints Michael Celano as CFO
Tuesday, 5 Jul 2016 

Recro Pharma Inc - :Recro Pharma appoints Michael Celano as chief financial officer.  Full Article

BRIEF-Recro Pharma Estimates Cash And Cash Equivalents About $64 Mln As Of Dec 31

* RECRO PHARMA - ESTIMATES THAT AS OF DEC 31, 2017, CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $64.0 MILLION Source text for Eikon: (http://bit.ly/2nOPGN7) Further company coverage: